APOQUEL (oclacitinib tablet), a prescription allergy medicine for dogs, that can provide safe, fast dog itch relief, is promoted in a commercial featuring a talking pug.
The spot features the dog and his owner at the vet, talking about their issue: the pet is scratching “like crazy”.
The specialist concludes that he’s got some allergic itch with skin inflammation and tells them that APOQUEL can work on that itch in as little as four hours whether it’s a new or chronic problem, mentioning that this medication has treated over 7 million dogs.
“Until dogs can speak for themselves, you have to,” the voiceover says toward the end of the commercial, which also features the pug using an online dating app similar to Tinder and having lunch with his owner in the city.
The voiceover also urges dog owners to ask for APOQUEL when allergic itch becomes a problem, specifying that APOQUEL is for the control of itch associated with allergic dermatitis and the control of atopic dermatitis in dogs. Viewers are also advised to not use APOQUEL in dogs less than 12 months of age or those with serious infections. Another piece of information provided through the ad is that APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse.
APOQUEL, from leading global animal health company Zoetis, was approved by the U.S. Food and Drug Administration in May 2013 and is the first and only Janus kinase (JAK) inhibitor approved for veterinary use.
APOQUEL was the Law Enforcement and Arson category sponsor for the 2019 American Humane Hero Dog Awards, an annual campaign that recognizes heroes on both ends of the leash.
In July 2019, Zoetis teamed up with actress and animal lover Kate Walsh for the “Show Us Your Dog’s A-Game” campaign, which aimed to bring awareness to how skin diseases and allergies affect a dog’s well-being and encourage pet owners to visit their veterinarians.